Growth Metrics

Repligen (RGEN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $12.6 million.

  • Repligen's Change in Accured Expenses rose 30709.45% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 38471.46%. This contributed to the annual value of $6.1 million for FY2024, which is 12837.62% up from last year.
  • Per Repligen's latest filing, its Change in Accured Expenses stood at $12.6 million for Q3 2025, which was up 30709.45% from -$4.8 million recorded in Q2 2025.
  • Over the past 5 years, Repligen's Change in Accured Expenses peaked at $13.1 million during Q4 2021, and registered a low of -$10.0 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was $746000.0 (2024), whereas its average is $810210.5.
  • As far as peak fluctuations go, Repligen's Change in Accured Expenses surged by 56332.18% in 2021, and later crashed by 56601.94% in 2025.
  • Repligen's Change in Accured Expenses (Quarter) stood at $13.1 million in 2021, then tumbled by 138.51% to -$5.1 million in 2022, then crashed by 77.87% to -$9.0 million in 2023, then soared by 108.29% to $746000.0 in 2024, then soared by 1592.23% to $12.6 million in 2025.
  • Its Change in Accured Expenses was $12.6 million in Q3 2025, compared to -$4.8 million in Q2 2025 and $1.8 million in Q1 2025.